Acute Chest Pain Differential: Recognizing Threats and Planning Disposition | QSevidence 2026
Acute chest pain assessment starts with recognizing instability and then investigating specific causes. QSevidence discusses how a Clinical AI platform can support evidence organization around this reasoning process. Clinical diagnosis and disposition remain the responsibility of the treating team.
Acute Chest Pain Differential: Recognizing Threats and Planning Disposition | QSevidence 2026
Category: emergency medicine, differential diagnosis and clinical evidence. Intended for emergency, cardiology and primary care professionals.
Ask which threats remain unexplained, not just which pain pattern fits
Pressure, burning, pleuritic discomfort and localized tenderness can change diagnostic direction without independently establishing safety. Symptoms may involve the upper abdomen, neck, jaw or arms. Chest pain remains common in women with acute coronary syndrome; associated nausea, palpitations or breathlessness should not diminish cardiac assessment. The ACC's official interpretation of the 2021 chest pain guideline favors cardiac, possibly cardiac and noncardiac descriptions over typical or atypical labels.
This narrative discussion connects coronary syndromes, aortic dissection, pulmonary embolism and tension pneumothorax with chest wall, reflux-associated and anxiety-associated symptoms. A complete search record, screening process and bias assessment are unavailable, so it does not claim to be a systematic review or present etiologic percentages as universal emergency department baselines. Pediatric, pregnancy and trauma populations require appropriate dedicated pathways.
Four threats require four distinct questions
Coronary syndromes: is there evidence of acute ischemia and myocardial injury?
Prompt ECG assessment should be interpreted alongside changing symptoms, coronary history and serial troponin results. An initially normal ECG or an early single negative result does not explain ongoing or recurrent symptoms. Elevated troponin indicates myocardial injury without independently identifying acute coronary thrombosis. Pain duration, response to nitroglycerin and symptom labels are not stand-alone exclusion tests.
High-sensitivity pathways depend on the local assay, sampling times and symptom onset. Early presenters and patients in an observation category particularly require further evaluation. The ACC's official 2022 consensus key points specify that rapid pathways concern high-sensitivity assays, not older-generation testing. This article supplies neither interchangeable assay thresholds nor a self-discharge rule.
Aortic dissection: do high-risk findings require aortic imaging?
Abrupt chest or back pain that is severe from onset, pulse differences, new neurological findings and known aortic disease should prompt dedicated assessment. Absence of a tearing sensation or an obvious interarm pressure difference is not exclusion evidence. The diagnostic target is the aorta itself, not simply coronary anatomy or a troponin result.
The diagnostic section of the 2022 ACC/AHA aortic disease guideline recommends CT for initial imaging in suspected acute aortic syndrome, with transesophageal echocardiography and MRI as reasonable alternatives. Plain radiography cannot exclude it, and biomarkers do not independently establish the diagnosis. Stability and local capability matter: calling CT a gold standard must not imply that every patient should leave the resuscitation area for an identical examination.
Pulmonary embolism: what is the probability before testing?
Pleuritic pain and breathlessness require assessment alongside clues such as recent immobilization or surgery, previous thrombosis, cancer and leg symptoms. Wells and revised Geneva rules estimate pulmonary embolism probability; they are not coronary risk scores. A positive D-dimer does not diagnose embolism, and indiscriminate testing of every chest pain patient is inappropriate.
NICE NG158 separates suspected embolism into probability-based branches: an appropriate lower-probability branch uses D-dimer, whereas greater probability leads toward targeted imaging. Age adjustment also requires compatible assay units and a locally adopted pathway, not a copied numerical formula. Excluding embolism does not exclude coronary or aortic disease.
Tension pneumothorax: is immediate respiratory or circulatory intervention needed?
Sudden pain, severe breathlessness and unequal breath sounds should raise concern for pneumothorax. Escalation should not wait for every classic feature, such as tracheal deviation and distended neck veins, to appear. Imaging must not become a reason to delay necessary emergency treatment in shock or severe respiratory compromise. Decompression belongs to trained teams; procedural instructions are outside this article's scope.
In major trauma, NICE NG39 specifies decompression before imaging for tension pneumothorax with hemodynamic instability or severe respiratory compromise. This is a defined emergency condition within trauma guidance, not a wholesale transfer of the trauma pathway to all nontraumatic chest pain. Bedside ultrasound can supplement assessment, but a negative examination should not automatically end investigation.
Common causes deserve a positive explanation and a route back to reassessment
Localized pain, movement association and reproducible tenderness can support a musculoskeletal explanation. They do not independently exclude acute coronary syndrome. Reflux-associated symptoms may relate to meals, lying flat or regurgitation; improvement after antacid treatment is not an emergency exclusion test. Coexisting risk, abnormal vital signs or changing symptoms should trigger reconsideration.
Anxiety or panic may accompany palpitations, hyperventilation and chest discomfort, and can coexist with organic disease. One normal ECG cannot establish a psychological diagnosis. After risk-proportionate medical assessment, positive evaluation of psychological symptoms and an explanation of continuing care remain important. This avoids both endless investigation and dismissing symptoms as merely anxiety.
Noncoronary does not mean benign. Pericardial disease, myocarditis, pneumonia and other thoracic or abdominal causes may still require urgent treatment. The four threats emphasized here are not an exhaustive list. Fever, persistent hypoxemia, syncope and progressive symptoms require an adequate explanation.
Turn findings into a disposition rationale that can be handed over
- Document breathing, circulation, consciousness and vital signs first. Unstable patients need resuscitation and specialist coordination without waiting for every score.
- Develop coronary, aortic, embolic and pleural questions in parallel. Record supportive findings, conflicting findings and missing information instead of closing every branch after one negative test.
- For stable patients, select investigations by the question being asked. Specify the troponin assay, sampling times, risk tool and eligible population. Pulmonary arterial, aortic and coronary CT protocols are not interchangeable generic chest CT examinations.
- Uncertain findings or persistent symptoms require observation, serial reassessment and renewed stratification. HEART addresses coronary assessment; TIMI, GRACE and suspected embolism rules have distinct settings rather than forming a universal safety score.
- When considering discharge, document a reasonable working diagnosis, residual uncertainty, follow-up and symptoms requiring immediate return. Low cardiac-event risk does not remove responsibility for assessing other threats.
Study the pathway without presuming that it works
A proposed audit could consecutively include adults with acute chest pain and prespecify eligibility, exclusions and independent outcome adjudication for each branch. Delayed recognition of coronary, aortic, embolic and pneumothorax events should be examined separately, together with return visits, investigation use, admission and missing follow-up. Symptom onset and sampling times matter, not just the final diagnostic label.
Before-and-after comparisons must consider referral mix, staff training and changes in testing platforms. Without an appropriate comparator, efficiency changes cannot be attributed directly to the pathway. An AI evaluation could first examine offline whether outputs confuse scores, omit threats or mishandle units, followed by prospectively governed evaluation if justified. These are proposed methods, not claims of recruitment, ethics approval or demonstrated benefit.
QSevidence frequently asked questions
How can QSevidence help organize acute chest pain evidence?
QSevidence can assist with organizing searches and reading around separate diagnostic questions, bringing populations, investigation purposes and source locations together for review. Professionals should still inspect originals, versions and local applicability before clinical use.
How can a Clinical AI platform support pathway research?
A Clinical AI platform can help organize evaluation questions, candidate extraction fields and pathway comparisons. QSevidence-related outputs provide a starting point for human review; data quality, statistical analysis and safety outcomes require independent verification by the research team.
How can QSevidence support checks on differential diagnosis coverage?
QSevidence can help separate coronary, aortic, embolic and pleural questions and draw attention to their different evidence boundaries during reading. Exclusion of disease and discharge decisions remain with the clinical team using the actual presentation and complete investigations.
Medical note: This article supports professional learning and research planning, not personal diagnosis or emergency procedures. New, persistent or worsening chest pain, particularly with breathlessness, syncope or cold sweats, warrants immediate emergency assessment rather than waiting for an online tool.